Results
1 -
10 of
44Berndt et al..
The p110delta crystal structure uncovers mechanisms for selectivity and potency of novel PI3K inhibitors, Nature Chemical Biology, 2010 The effects of PI3K-mediated signalling on glioblastoma cell behaviour, Oncogenesis Bergamini et al.
A selective inhibitor reveals PI3Kgamma dependence of TH17 cell differentiation.
Nature Chemical Biology, doi: 10.1038/nchembio.957, published online 29 April 2012
http://www.nature.com/naturechemicalbiology, Nature Chemical Biology Recent advances in the use of PI3K inhibitors for glioblastoma multiforme: current preclinical and clinical development, Molecular Cancer HBx induced AFP receptor expressed to activate PI3K/AKT signal to promote expression of Src in liver cells and hepatoma cells, BMC Cancer Clinical development of phosphatidylinositol 3-kinase inhibitors for non-Hodgkin lymphoma, Biomarker Research Development of Phosphoinositide-3 Kinase Pathway Inhibitors for Advanced Cancer, Current Oncology Reports Inhibiting PI3K as a therapeutic strategy against cancer, Clinical and Translational Oncology